Champion the development of Owkin's AI Scientist, an agentic system for target and drug discovery.
Lead projects to discover novel drug targets and biomarkers using multimodal patient data and machine learning.
Collaborate closely with biomedical teams and Owkin's Research Technology team to shape tools for pharmaceutical partners.
Owkin is an agentic AI company pioneering Biological Artificial Superintelligence to solve problems in biology. They offer a flexible work organization and a friendly, informal working environment with an international team.
Design advanced biology problems that challenge frontier AI systems in molecular biology, genetics, or computational biology.
Create deterministic tasks with exactly one correct answer and submit complete, verified solutions.
Use Python and bioinformatics tools to build problems involving experimental reasoning and computational analysis.
We create high-quality STEM training data for frontier AI models used by leading AI labs. We are a team of experts working to improve model reasoning in scientific domains.
Play a key role in expanding the spatial biology platform and service offerings by designing and optimizing targeted in situ transcriptomics panels.
Develop computational methods, software tools, and analysis pipelines for spatial transcriptomics and multiomics data.
Collaborate with R&D teams to improve probe performance and enable biological interpretation from spatial data.
Singular Genomics invents at the forefront of genomics, developing the G4 Sequencing Platform and G4X Spatial Sequencer. They foster a culture of creativity and technical excellence, celebrating diversity and collaboration as they rapidly mature.
Drive core research: Collaborate with the technical founder and team to develop cutting-edge modeling approaches and iterate rapidly.
Develop RL feedback loop: Design and implement post-training methods that translate high-throughput biological measurements into reward signals.
Bridge wet/dry lab: Partner with experimental team to ensure lab measurements and model learning are designed as a single cohesive system.
Astera is a private foundation on a mission to steer science and technology toward an abundant future. Projects supported by Astera operate like high-velocity startups, focusing on ambitious goals and attracting strong technical talent.
Lead analysis and interpretation of cancer's molecular signatures, guiding model development for biological changes.
Execute rigorous computational analyses on data from high-throughput molecular assays including sequencing and protein quantitation.
Partner with molecular biologists and development scientists to refine experiments and turn research models into products.
Freenome is a biotechnology company developing blood tests for early cancer detection. We are a growing organization dedicated to changing the landscape of cancer, with a collaborative and diverse team.
Drive product vision and strategy for AI and Lab Products at Absci.
Lead interdisciplinary teams of AI/ML researchers, engineers, and scientists to build delivery platforms.
Serve as bridge between AI Research and Biologics Discovery Technology teams for drug design and target identification.
Absci is a clinical-stage biotechnology company using generative AI to design novel therapeutics. It is a global company headquartered in Vancouver, WA, with offices in New York City, Switzerland, and Serbia.
Contribute to technical approach for evaluating AI agents' reasoning through biological function, recovering and interpreting experimental evidence.
Build ground-truth benchmark datasets from real discovery programs to test agents' quantitative reasoning capabilities.
Use expertise in functional biology assays and computational modeling to define metrics for agent capability in biological sequences and structures.
LatchBio builds intelligent, high-performance agents for biological data analysis, empowering over 5,000 scientists across 150+ R&D labs. They work at the frontier of artificial intelligence in biology.
Lead the scientific strategy for predictive toxicology and quantitative biology in drug discovery.
Develop advanced ML models using graph neural networks, transformers, and federated learning.
Collaborate with customers and partners to integrate AI solutions into real-world workflows.
The company is a partner of Jobgether, specializing in AI-powered solutions for life sciences and drug discovery. They are a remote-first organization with a highly skilled international team and a collaborative culture.
Lead the analysis and interpretation of molecular and clinical data in the context of early cancer detection.
Develop bioinformatics pipelines to enable high throughput NGS data processing and analysis.
In collaboration with wet lab scientists, rapidly characterize and iterate on experimental methods.
Freenome is a biotechnology company developing early, noninvasive cancer detection tests using cfDNA biomarkers. They are an equal opportunity employer with a collaborative, cross-functional team environment.
Lead development of Dyno’s external-facing AI platforms (e.g., design.dynotx.com)
Develop field-relevant benchmarks for agentic tasks in biological design
Build and improve AI-driven workflows that integrate models, data systems, and experimental feedback
Dyno Therapeutics is a biotech company that develops AI-driven genetic technologies to transform patient lives. They are a high-energy, high-impact team of world-class scientists and engineers working at the intersection of AI and genetic medicine.
Serve as study statistician or support statistician on Bronchiectasis or Hepatitis B programs, responsible for protocol development, study design, sample size calculation, randomization, and statistical analysis plans.
Provide statistical oversight to studies, assure data completeness and accuracy, and ensure validity of analysis and alternative strategies when unforeseen circumstances arise.
Demonstrate extensive understanding of statistical concepts, correct flaws in reasoning and interpretation, and ensure accuracy of statistical tables, figures, and report text.
ClinChoice is a global full-service CRO specializing in clinical development and functional solutions for pharmaceutical, biotechnology, medical device, and consumer health companies. With over 28 years of experience and more than 4,000 professionals in over 20 countries across the Americas, Europe, and Asia-Pacific, the company emphasizes quality, professional development, and a supportive culture.
Define and enforce quality standards for motion and static creative through review and coaching, while owning the team's delivery speed from brief to launch.
Own the team's production stack, evaluate and train on AI-assisted creative workflows, and build reusable systems to scale output without scaling headcount.
Translate performance data (CTR, CVR, CPA) into concrete creative direction, partnering with the user acquisition team and owning localization QA.
Ruby Labs is a leading tech company that creates and operates innovative consumer products across health, education, and entertainment industries. They are a fast-growing, ambitious team that values high standards, speed, and results, offering significant upside for strong operators.
Leads statistical activities for clinical studies in oncology.
Authors statistical sections of study protocols, analysis plans, and regulatory documents.
Collaborates with cross-functional teams and CROs to ensure high-quality deliverables.
Iovance Biotherapeutics develops tumor infiltrating lymphocyte (TIL) therapy for cancer treatment. The company is a global leader in cell therapy innovation with a focus on clinical data and regulatory submissions.
Co-direct the research program in partnership with the founder to shape scientific vision and technical execution.
Develop RL feedback loops translating high-throughput biological measurements into reward signals for biological language models.
Perform hands-on engineering including architecting model training infrastructure and building, running, and debugging models.
Astera is a private foundation steering science and technology toward an abundant future by supporting projects as high-velocity startups. It operates unlike traditional non-profits, focusing on ambitious goals with strong technical talent and significant resources.